Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer

OBJECTIVE: The addition of bevacizumab to fluoropyrimidine-based combination chemotherapy as first-line therapy for metastatic colorectal cancer results in clinically significant improvements in patient outcome. However, clinical trials have been conducted primarily in Caucasian patients with only a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Doi, Toshihiko, Boku, Narikazu, Kato, Ken, Komatsu, Yoshito, Yamaguchi, Kensei, Muro, Kei, Hamamoto, Yasuo, Sato, Atsushi, Koizumi, Wasaburo, Mizunuma, Nobuyuki, Takiuchi, Hiroya
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2010
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947844/
https://ncbi.nlm.nih.gov/pubmed/20462981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyq069
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires